Advertisement

Radiation-Induced Lung and Heart Toxicity

  • Timothy D. Shafman
  • Xiaoli Yu
  • Zjelko Vujaskovic
  • Mitchell Anscher
  • Keith Miller
  • Robert Prosnitz
  • Lawrence Marks
Part of the Medical Radiology Radiation Oncology book series (MEDRAD)

Keywords

Single Photon Emission Compute Tomography Lung Injury Radiat Oncol Biol Phys Radiation Pneumonitis Early Breast Cancer Trialist 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abid S, Malhotra V, Perry M (2001) Radiation-induced and chemotherapy-induced pulmonary injury. Curr Opin Oncol 13:242–248CrossRefPubMedGoogle Scholar
  2. Abid SH, Malhotra V, Perry MC (2001) Radiation-induced and chemotherapy-induced pulmonary injury. Curr Opin Oncol 13:242–8CrossRefPubMedGoogle Scholar
  3. Abratt RP, Willcox PA, Smith JA (1990) Lung cancer in patients with borderline lung functions—zonal lung perfusion scans at presentation and lung function after high dose irradiation. Radiother Oncol 19:317–322CrossRefPubMedGoogle Scholar
  4. Adams MJ, Hardenbergh PH, Constine LS, et al.(2003b) Radiation-associated cardiovascular disease. Crit Rev Oncol Hematol 45:55–75PubMedGoogle Scholar
  5. Adams MJ, Lipshultz SE, Schwartz C, et al.(2003a) Radiation-associated cardiovascular disease: manifestations and management. Semin Radiat Oncol 13:346–56CrossRefPubMedGoogle Scholar
  6. Amromin GD, Gildenhorn HL, Solomon RD, et al (1964) The Synergism of X-Irradiation and Cholesterol-Fat Feeding on the Development of Coronary Artery Lesions. J Atheroscler Res 24:325–34PubMedGoogle Scholar
  7. Anscher MS, Marks LB, Shafman TD, et al (2001) Using plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation. J Clin Oncol 19:3758–3765PubMedGoogle Scholar
  8. Anscher MS, Marks LB, Sherouse G, et al (1994) Changes in plasma transforming growth factor-beta levels during pulmonary irradiation. Int J Radiat Oncol Biol Phys. 30:671–676PubMedGoogle Scholar
  9. Antonadou D, Coliarkis N, Synodinou M, et al (2002) A randomized phase III trial of radiation treatment +/− ami-fostine in patients with advanced-stage lung cancer. Int J Radiat Oncol Biol Phys 51:915–922CrossRefGoogle Scholar
  10. Applefeld MM, Wiernik PH (1983) Cardiac disease after radiation therapy for Hodgkin's disease: analysis of 48 patients. Am J Cardiol 51:1679–81CrossRefPubMedGoogle Scholar
  11. Armstrong JG, Zelefsky MF, Leibel SA, et al (1995) Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer. Ann Oncol 6:693–697PubMedGoogle Scholar
  12. Artom C, Lofland HB, Jr., Clarkson TB (1965) Ionizing radiation, atherosclerosis, and lipid metabolism in pigeons. Radiat Res 26:165–77PubMedGoogle Scholar
  13. Belberbos JSA, De Jagier K, Heemsbergen WD, et al (2003) First results of a phase I/II dose escalation trial in non-small cell lung cancer using three dimensional conformal radiotherapy. Radiotherapy & Oncology 66:119–126Google Scholar
  14. Bell J, McGivern D, Bullimore J, Hill J, Davies ER, Goodard P (1988) Diagnostic imaging of post-irradiation changes in the chest. Clin Radiol 39:109–119CrossRefPubMedGoogle Scholar
  15. Boivin JF, Hutchison GB, Lubin JH, et al (1992) Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer 69:1241–7PubMedGoogle Scholar
  16. Boivin JF, Hutchison GB (1982) Coronary heart disease mortality after irradiation for Hodgkin's disease. Cancer 49:2470–5PubMedGoogle Scholar
  17. Bonnet RB, Bush D, Cheek GA, Slater JD, Panossian D, Franke C, et al (2001) Effects of proton and combined proton/photon beam radiation on pulmonary function on patients with resectable but medically inoperable non-small cell lung cancer. Chest 120:1803–1CrossRefPubMedGoogle Scholar
  18. Brach MA, Hass R, Sherman ML, et al (1991) Ionizing radiation induces expression and binding activity of the nuclear factor kappa B. J Clin Invest 88: 691–5PubMedGoogle Scholar
  19. Brady LW, Germon PA, Cander L (1965) The effects of radiation therapy on pulmonary function in carcinoma of the lung. Radiology 85:130–134PubMedGoogle Scholar
  20. Brierley JD, Rathmell AJ, Gospodarowicz MK, et al (1998) Late effects of treatment for early-stage Hodgkin's disease. Br J Cancer 77:1300–10PubMedGoogle Scholar
  21. Byhardt RW, Martin L, Pajak TF, et al (1993) The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)—analysis of a Radiation Therapy Oncology GrGoogle Scholar
  22. Capizzi RL (1999) The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine. Semin Oncol 26:3–21Google Scholar
  23. Carmel RJ, Kaplan HS (1976) Mantle irradiation in Hodgkin's disease. An analysis of technique, tumor eradication, and complications. Cancer 37:2813–25PubMedGoogle Scholar
  24. Chen Y, Williams J, Hernady E, et al (2002) Radiation pneumonitis and early circulatory cytokine markers. Semin Radiat Oncol 12(1 Suppl 1):26–33CrossRefPubMedGoogle Scholar
  25. Choi N, Kanarek DJ, Kazemi H (1985) Physiologic changes in pulmonary function after thoracic radiotherapy for patients with lung cancer and role of regional pulmonary function studies in predicting post-radiotherapy pulmonary function before radiotherapy.Google Scholar
  26. Choi NC, Kanarek DJ (1994) Toxicity of thoracic radiotherapy on pulmonary function in lung cancer. Lung Cancer 10(Suppl 1): S219–S230CrossRefPubMedGoogle Scholar
  27. Constine LS, Schwartz RG, Savage DE, et al (1997) Cardiac function, perfusion, and morbidity in irradiated long-term survivors of Hodgkin's disease. Int J Radiat Oncol Biol Phys 39:897–906CrossRefPubMedGoogle Scholar
  28. Cosset JM, Henry-Amar M, Girinski T, et al (1988) Late toxicity of radiotherapy in Hodgkin's disease. The role of fraction size. Acta Oncol 27:123–9PubMedGoogle Scholar
  29. Cosset JM, Henry-Amar M, Pellae-Cosset B, et al (1991) Pericarditis and myocardial infarctions after Hodgkin's disease therapy. Int J Radiat Oncol Biol Phys 21:447–9PubMedGoogle Scholar
  30. Curran WJ, Moldofsky PJ, Solin LJ (1992) Observations on the predictive value of perfusion lung scans on post-irradiation pulmonary function among 210 patients with bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 24:31–36PubMedGoogle Scholar
  31. Cuzick J, Stewart H, Peto R, et al (1987) Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep 71:15–29PubMedGoogle Scholar
  32. Cuzick J, Stewart H, Rutqvist L, et al (1994) Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 12:447–53PubMedGoogle Scholar
  33. Dautzenberg B, Arriagada R, Chammard AB, et al (1999) A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Groupe d'Etude et de Traitement des Cancers Bronchiques. Cancer 86:265–73CrossRefPubMedGoogle Scholar
  34. Dechambre S, Dorzee J, Fastrez J, et al (1998) Bronchial stenosis and sclerosing mediastinitis: an uncommon complication of external thoracic radiotherapy. Eur Respir J 11:1188–1190CrossRefPubMedGoogle Scholar
  35. Dillman RO, Seagren SL, Propert KJ, et al (1990) A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer. N Engl J Med 323:940–5PubMedGoogle Scholar
  36. Early Breast Cancer Trialists’ Collaborative Group (1990) Treatment of Early Breast Cancer. Oxford, UK, Oxford UniversityGoogle Scholar
  37. Early Breast Cancer Trialists’ Collaborative Group (1995) Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med 333:1444–55Google Scholar
  38. Early Breast Cancer Trialists’ Collaborative Group (2000) Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 355:1757–70Google Scholar
  39. Epperly M, Travis E, Sikora C, et al (1999) Magnesium superoxide dismutase (MnSOD) plasmid/liposome pulmonary radioprotective gene therapy: modulation of irradiation-induced mRNA for IL-1, TNF-α, and TGF-β correlates with delay of organizing alveolitis/fibGoogle Scholar
  40. Fan M, Marks LB, Hollis D, et al (2001) Can we predict radiation-induced changes in pulmonary function based on the sum of predicted regional dysfunction? J Clin Oncol 19:543–550PubMedGoogle Scholar
  41. Favaretto A, Paccagnella A, Tomio L, Sartori F, Cipriani A, Zuin R, et al (1996) Pre-operative chemoradiotherapy in non-small cell lung cancer stage III patients. Feasibility, toxicity and long-term results of a phase II study. Europ J Cancer 32A:2064–2069CrossRefGoogle Scholar
  42. Finkelstein J, Johnston C, Baggs R, et al (1994) Early alteration in extracellular matrix and transforming growth factor ß gene expression in mouse lung indicative of late radiation fibrosis. Int J Radiat Oncol Biol Phys 28:621–631PubMedGoogle Scholar
  43. Ford EC, Mageras GS, Yorke E, et al (2002) Evaluation of respiratory movement during gated radiotherapy using film and electronic portal imaging. Int J Radiat Oncol Biol Phys 52:522–531CrossRefPubMedGoogle Scholar
  44. Franko AJ, Sharplin J, Ghahary A, et al (1997) Immunohisto-chemical localization of transforming growth factor beta and tumor necrosis factor alpha in the lungs of fibrosis-prone and “non-fibrosing” mice during the latent period and early phase after irradGoogle Scholar
  45. Furuse K, Fukuoka M, Kawahara M, et al (1999) Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and Cisplatin in unresectable stage III non-small cell lung cancer. J Clin Oncol 17:2692–2699PubMedGoogle Scholar
  46. Fu XL, Huang H, Bentel G, et al (2001) Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V30 and transforming growth factor B. Int J Radiat Oncol Biol Phys 50:899–908CrossRefPubMedGoogle Scholar
  47. Fu XL, Jiang GL, Wang LJ, Qian H, Fu S, Yie M, et al (1997) Hyperfractionated accelerated radiation therapy for non-small cell lung cancer: clinical phase I/II trial. Int J Radiat Oncol Biol Phys 39:545–552CrossRefPubMedGoogle Scholar
  48. Garipagaoglu M, Munley MT, Hollis D, Poulson JM, Bentel GC, Sibley G, Anscher MS, Fan M, Jaszczak RJ, Coleman RE, Marks LB (1999) The effect of patient-specific factors on radiation induced regional lung injury. Int J Radiat Oncol Biol Phys 45:331–338CrossRefPubMedGoogle Scholar
  49. Garipagaoglu M, Munley MT, Hollis D, Poulson JM, Bentel GC, Sibley G, Anscher MS, Fan M, Jaszczak RJ, Coleman RE, Marks LB (1999) The effect of patient-specific actors on radiation induced regional lung injury. Int J Radiat Oncol Biol Phys 45: 331–338CrossRefPubMedGoogle Scholar
  50. Geist BJ, Lauk S, Bornhausen M, et al (1990) Physiologic consequences of local heart irradiation in rats. Int J Radiat Oncol Biol Phys 18:1107–13PubMedGoogle Scholar
  51. Gomez GA, Park JJ, Panahon AM, et al (1983) Heart size and function after radiation therapy to the mediastinum in patients with Hodgkin's disease. Cancer Treat Rep 67:1099–103PubMedGoogle Scholar
  52. Gottdiener JS, Katin MJ, Borer JS, et al (1983) Late cardiac effects of therapeutic mediastinal irradiation. Assessment by echocardiography and radionuclide angiography. N Engl J Med 308:569–72PubMedGoogle Scholar
  53. Graham M, Purdy J, Emami B, Harms W, Bosch W, Lockett M, et al (1999) Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45:323–329CrossRefPubMedGoogle Scholar
  54. Grills IS, Yan D, Martinez AA, Vicini FA, Wong JW, Kestin LL (2003) Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radGoogle Scholar
  55. Gross NJ (1977) Pulmonary effects of radiation therapy. Ann Intern Med 86:81–92PubMedGoogle Scholar
  56. Gross NJ (1977) Pulmonary effects of radiation therapy. Ann Intern Med 86: 81–92PubMedGoogle Scholar
  57. Gross NJ (1980) Experimental radiation pneumonitis. IV. Leakage of circulatory proteins onto the alveolar surface. J Lab Clin Med 95(1): 19–31PubMedGoogle Scholar
  58. Gustavsson A, Eskilsson J, Landberg T, et al (1990) Late cardiac effects after mantle radiotherapy in patients with Hodgkin's disease. Ann Oncol 1:355–63PubMedGoogle Scholar
  59. Gyenes G, Rutqvist LE, Liedberg A, et al (1998) Long-term cardiac morbidity and mortality in a randomized trial of pre-and postoperative radiation therapy versus surgery alone in primary breast cancer. Radiother Oncol 48:185–90CrossRefPubMedGoogle Scholar
  60. Gyenes G (1998) Radiation-induced ischemic heart disease in breast cancer—a review. Acta Oncologica 37:241–6CrossRefPubMedGoogle Scholar
  61. Hallahan DE, Spriggs DR, Beckett MA, et al (1990) Increased tumor necrosis factor alpha mRNA after cellular exposure to ionizing radiation. Proc Natl Acad Sci USA 86:10104–7Google Scholar
  62. Hallahan DE, Virudachalam S, Beckett M, et al (1991) Mechanisms of X-ray-mediated protooncogene c-jun expression in radiation-induced human sarcoma cell lines [published erratum appears in Int J Radiat Oncol Biol Phys 1992; 22(4):829]. Int J Radiat Oncol BGoogle Scholar
  63. Hallahan DE, Virudachalam S, Kufe DW, et al (1994) Keto-conazole attenuates radiation induction of tumor necrosis factor. Int J Radiat Oncol Biol Phys 29: 777–80PubMedGoogle Scholar
  64. Hallahan DE, Virudachalam S (1997) Intercellular adhesion molecule 1 knockout abrogates radiation induced pulmonary inflammation. Proc Natl Acad Sci U S A 94:6432–7CrossRefPubMedGoogle Scholar
  65. Hallahan DE, Virudachalam S (1997) Ionizing radiation mediates expression of cell adhesion molecules in distinct histological patterns within the lung. Cancer Res 57:2096–9PubMedGoogle Scholar
  66. Hancock SL, Donaldson SS, Hoppe RT (1993a) Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol 11:1208–15PubMedGoogle Scholar
  67. Hancock SL, Hoppe RT (1996) Long-Term Complications of Treatment and Causes of Mortality After Hodgkin's Disease. Semin Radiat Oncol 6:225–242PubMedGoogle Scholar
  68. Hancock SL, Tucker MA, Hoppe RT (1993b) Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. Jama 270:1949–55CrossRefPubMedGoogle Scholar
  69. Hardenbergh PH, Munley MT, Bentel GC, et al (2001) Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: preliminary results. Int J Radiat Oncol Biol Phys 49:1023–8CrossRefPubMedGoogle Scholar
  70. Haston CK, Zhou X, Gumbiner-Russo L, Irani R, Dejournett R, Gu X, Weil M, Amos CI, and Travis EL (2002) Universal and radiation-specific loci influence murine susceptibility to radiation-induced pulmonary fibrosis. Cancer Res 62: 3782–3788PubMedGoogle Scholar
  71. Henry-Amar M, Hayat M, Meerwaldt JH, et al (1990) Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocols. EORTC Lymphoma Cooperative Group. Int J Radiat Oncol Biol Phys 19:1155–7PubMedGoogle Scholar
  72. Hernando M, Marks L, Bentel G, Zhou SM, Hollis D, Das S, et al (2001) Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 51:650–659CrossRefPubMedGoogle Scholar
  73. Hong JH, Chiang CS, Campbell IL, et al (1995) Induction of acute phase gene expression by brain irradiation. Int J Radiat Oncol Biol Phys 33: 619–26CrossRefPubMedGoogle Scholar
  74. Hong JH, Chiang CS, Sun JR, et al (1997) Induction of c-fos and junB mRNA following in vivo brain irradiation. Brain Res Mol Brain Res 48: 223–8CrossRefPubMedGoogle Scholar
  75. Host H, Brennhovd IO, Loeb M (1986) Postoperative radiotherapy in breast cancer—long-term results from the Oslo study. Int J Radiat Oncol Biol Phys 12:727–32PubMedGoogle Scholar
  76. Inoue A, Kunitoh H, Sekine I, Sumi M, Tokuuye K, Saijo N (2000) Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis. Int J Radiat Oncol Biol Phys 49:649–655CrossRefGoogle Scholar
  77. Jakacki RI, Goldwein JW, Larsen RL, et al (1993) Cardiac dysfunction following spinal irradiation during childhood. J Clin Oncol 11:1033–8PubMedGoogle Scholar
  78. Jiresova A, Wiegman EM, Kampinga HH, et al (2002) Dose-volume-region effects in partial irradiation of the rat lung. Programs and Abstracts, Radiation Research Society and North American Hyperthermia Society: 114, #103Google Scholar
  79. Johnston C, Piedboeuf B, Baggs R, et al (1995) Differences in correlation of mRNA gene expression in mice sensitive and resistant to radiation-induced pulmonary fibrosis. Radiat Res 142:197–203PubMedGoogle Scholar
  80. Johnston CJ. Williams JP. Okunieff P. Finkelstein JN (2002) Radiation-induced pulmonary fibrosis: examination of chemokine and chemokine receptor families. Radiation Res 157(3):256–65PubMedGoogle Scholar
  81. Jones JM, Ribeiro GG (1989) Mortality patterns over 34 years of breast cancer patients in a clinical trial of post-operative radiotherapy. Clin Radiol 40:204–8CrossRefPubMedGoogle Scholar
  82. Katzenstein AA, Askin FB (1990) In: Surgical pathology of non-neoplastic lung disease. Saunders, PhiladelphiaGoogle Scholar
  83. Kelly K, Pan Z, Murphy J, et al (1997) A phase I trial of paclitaxel plus carboplatin in untreated patients with advanced non-small cell lung cancer. Clin Cancer Res 3:1117–23PubMedGoogle Scholar
  84. Komaki R, Lee JS, Kaplan B, et al (2002) Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: Preliminary results. Semin Radiat Oncol 12 (Google Scholar
  85. Kwa SLS, Theuws JCM, Wagenaar A, et al (1998) Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis. Radiother Oncol 48:61–69CrossRefPubMedGoogle Scholar
  86. Kwon HC, Kim SK, Chung WK, Cho MJ, Kim JS, Kim JS, et al (2000) Effect of pentoxifylline on radiation response of non-small cell lung cancer: a phase III randomized multicenter trial. Radiother Oncol 56:175–179CrossRefPubMedGoogle Scholar
  87. Lagrange JL, Darcourt J, Benoliel J, et al (1992) Acute cardiac effects of mediastinal irradiation: assessment by radionuclide angiography. Int J Radiat Oncol Biol Phys 22:897–903PubMedGoogle Scholar
  88. Lauk S, Trott KR (1988) Radiation induced heart disease in hypertensive rats. Int J Radiat Oncol Biol Phys 14:109–14PubMedGoogle Scholar
  89. Libshitz HI, Shuman LS (1984) Radiation-induced pulmonary change: CT findings. J Comput Assist Tomogr 8:15–19PubMedGoogle Scholar
  90. Lind P, Marks LB, Hollis D, et al (2002) Receiver operator curves (ROC) analysis of predictors for radiation-induced symptomatic lung injury. Int J Radiat Oncol Biol Phys 54:340–347CrossRefPubMedGoogle Scholar
  91. Maguire PD, Marks LB, Sibley GS, Herndon JE, Clough RW, Light KL, Hernando ML, Antoine PA, Anscher MS (2001) 73.6 Gy and beyond: Hyperfractionated, accelerated radiotherapy for non-small cell lung cancer. J Clin Oncol 19:705–711PubMedGoogle Scholar
  92. Mah K, Keane TJ. Van Day J, et al (1994) Quantitative effect of combined chemotherapy and fractionated radiotherapy on the incidence of radiation-induced lung damage: A prospective clinical study. Int J Radiat Oncol Biol Phys 28:563–574PubMedGoogle Scholar
  93. Mah K, Poon PY, Van Dyk J, Keane TJ, Majesky LF, Rideout DF (1986) Assessment of acute radiation-induced pulmonary changes using computed tomography. J Comput Assist Tomogr 10:736–743PubMedGoogle Scholar
  94. Mah K, Van Dyk J, Keane T, Poon PY (1987) Acute radiation-induced pulmonary damage: A Clinical study on the response to fractionated radiation therapy. Int J Radiat Oncol Biol Phys 13: 179–188PubMedGoogle Scholar
  95. Makimoto T, Tsuchiya S, Hayakawa K, Saitoh R, Mori M (1998) Risk factors for severe radiation pneumonitis in lung cancer. Japanese J Clini Oncol 29:192–197CrossRefGoogle Scholar
  96. Makinen L, Makipernaa A, Rautonen J, et al (1990) Long-term cardiac sequelae after treatment of malignant tumors with radiotherapy or cytostatics in childhood. Cancer 65:1913–7PubMedGoogle Scholar
  97. Marks LB, Hollis D, Munley M, et al (2000) The role of lung perfusion imaging in predicting the direction of radiation-induced changes in pulmonary function tests. Cancer 88:2135–2141CrossRefPubMedGoogle Scholar
  98. Marks LB, Spencer DP, Bentel GC, Ray SJ, Sherouse GW, Sontag MR, Coleman RE, Jaszczak RJ, Turkington TG, Tapson V, Prosnitz LR (1993) The utility of SPECT lung perfusion scans in minimizing and assessing the physiologic consequences of thoracic irradiationGoogle Scholar
  99. Marks LB, Yu X, Zhou S, et al (2003) The impact of irradiated left ventricular volume on the incidence of radiation-induced cardiac perfusion changes. Int J Radiat Oncol Biol Phys 57:S129CrossRefGoogle Scholar
  100. Marnitz S, Stuschke M, Bohsung J, Moys A, Reng I, Wurm R, Budach V (2002) Intra-individual comparison of conventional three-dimensional radiotherapy and intensity modulated radiotherapy in the therapy of locally advanced non-small cell lung cancer a planniGoogle Scholar
  101. Martel M, Ten Haken R, Hazuka M, Turrisi A, Fraass B, Lichter A (1994) Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int J Radiat Oncol Biol Phys 28:575–581PubMedGoogle Scholar
  102. Mattson K, Holsti LR, Poppius H, Korhola O, Stenman S, Tammilehto L, et al (1987) Radiation pneumonitis and fibrosis following split-course radiation therapy for lung cancer: A radiologic and physiologic study. Acta Oncol 26:193–196PubMedGoogle Scholar
  103. McDonald S, Rubin P, Phillips, et al (1995) Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints, and potential scoring systems. Int J Radiat Oncol Biol Phys 31:1187–1203CrossRefPubMedGoogle Scholar
  104. McDonald S, Rubin P, Phillips TL, Marks LB (1995) Injury to the lung from cancer therapy: Clinical syndromes, measurable endpoints, and potential scoring systems. Int J Radiat Oncol Biol Phys 31:1187–1203CrossRefPubMedGoogle Scholar
  105. Miller KL, Shafman TD, Anscher MS, et al (2004) Bronchial stenosis: An under-reported complication of high dose external beam radiotherapy for lung cancer? In PressGoogle Scholar
  106. Monson J, Stark P, Reilly J, Sugarbaker D, Strauss G, Swanson S, et al (1998) Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma. Cancer 82:842–850CrossRefPubMedGoogle Scholar
  107. Morgan G, Pharm B, Breit S (1995) Radiation and the lung: A reevaluation of the mechanisms mediating pulmonary injury. Int J Radiat Oncol Biol Phys 31: 361–369CrossRefPubMedGoogle Scholar
  108. Ng AK, Bernardo MP, Weller E, et al (2002) Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. J Clin Oncol 20:2101–8CrossRefPubMedGoogle Scholar
  109. Nyman J, Bergman B, Mercke C (1998) Accelerated hyperfractionated radiotherapy combined with induction and concomitant chemotherapy for inoperable non-small cell lung cancer. Acta Oncologica 1998. 37:539–545CrossRefGoogle Scholar
  110. Oetzel D, Schraube P, Hensley F, Sroka-Perez G, Menke M, Flentje M (1995) Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 33:455–460CrossRefPubMedGoogle Scholar
  111. Overgaard M, Hansen PS, Overgaard J, et al (1997) Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337:949–55CrossRefPubMedGoogle Scholar
  112. Overgaard M, Jensen MB, Overgaard J, et al (1999) Postoperative radiotherapy in high-risk postmenopausal, breast cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353:1641–8CrossRefPubMedGoogle Scholar
  113. Paszat LF, Mackillop WJ, Groome PA, et al (1998) Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries. J Clin Oncol 16:2625–31PubMedGoogle Scholar
  114. Perez CA, Stanley K, Rubin P, Kramer S, Brady LW, Marks JE, et al (1980) A prospective randomized study of various radiation doses and fractionation schedules in the treatment of inoperable non-small cell carcinoma of the lung. Cancer 1980; 45:2744–2753Google Scholar
  115. Perry M, Eaton WL, Propert KJ, Ware JH, Zimmer B, Chahinian AP, et al (1987) Chemotherapy with or without radiation therapy in limited small cell carcinoma of the lung. N Engl J Med 316:912–918PubMedGoogle Scholar
  116. Pohjola-Sintonen S, Totterman KJ, Salmo M, et al.(1987) Late cardiac effects of mediastinal radiotherapy in patients with Hodgkin's disease. Cancer 60:31–7PubMedGoogle Scholar
  117. PORT Meta-analysis Trialists Group (1998) Postoperative radiotherapy in non-small cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet 352:257–63Google Scholar
  118. Prato FS, Kurdyak R, Saibil EA, Rider WD, Aspin N (1997) Physiological and radiographic assessment during the development of pulmonary radiation fibrosis. Radiology 122: 389–397Google Scholar
  119. Ragaz J, Jackson SM, Le N, et al (1997) Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337:956–62CrossRefPubMedGoogle Scholar
  120. Roach M, Gandara DR, Yuo HS, et al (1995) Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors. J Clin Oncol 13:2606–2612PubMedGoogle Scholar
  121. Robnett, TJ, Machtay M, Vines EF, et al (2000) Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 48:89–94CrossRefPubMedGoogle Scholar
  122. Robnett T, Machtay M, Vines E, McKenna M, Algazy K, McKenna W (2000) Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 48:89–94CrossRefPubMedGoogle Scholar
  123. Rosenzweig KE, Sim SE, Mychalczak B, Braban LE, Schindelheim R, Leibel SA (2001) Elective nodal irradiation in the treatment of non-small cell lung cancer with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 50(3):681–5CrossRefPubMedGoogle Scholar
  124. Rosiello RA, Merrill WW (1990) Radiation-induced lung injury. Clinics Chest Med 11: 65–71Google Scholar
  125. Roswit B, White DC (1977) Severe radiation injuries of the lung. AJR Am J Roentgenol 129(1): 127–136PubMedGoogle Scholar
  126. Rubenstein JH, Richter MP, Moldofsky PJ, et al (1988) Prospective prediction of post-radiation therapy lung function using quantitative lung scans and pulmonary function testing. Int J Radiat Oncol Biol Phys 15:83–87PubMedGoogle Scholar
  127. Rubin P, Casarett GW (1968) Clinical radiation pathology as applied to curative radiotherapy. Cancer 22:767–78PubMedGoogle Scholar
  128. Rubin P, Johnston CJ, Williams JP, McDonald S, Finkelstein JN (1995) A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis Int J Radiat Oncol Biol Phys 33(1): 99–109CrossRefPubMedGoogle Scholar
  129. Rubin P, Shapiro DL, Finklestein JN, Penney DP (1980) The early release of surfactant following lung irradiation of alveolar type 11 cells. Int J Radiat Oncol Biol Phys 6(1): 75–77PubMedGoogle Scholar
  130. Rubin P, Siemann DW, Shapiro DL, Finkelstein JN, Penney DP (1983) Surfactant release as an early measure of radiation pneumonitis. Int J Radiat Oncol Biol Phys 9(11): 1669–1673PubMedGoogle Scholar
  131. Rutqvist LE, Johansson H (1990) Mortality by laterality of the primary tumour among 55,000 breast cancer patients from the Swedish Cancer Registry. Br J Cancer 61:866–8PubMedGoogle Scholar
  132. Rutqvist LE, Lax I, Fornander T, et al (1992) Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys 22:887–96PubMedGoogle Scholar
  133. Segawa Y, Takigawa N, Kataoka M, Takata I, Fujimoto N, Ueoka H (1997) Risk factors for development of radiation pneumonitis following radiation therapy with or without chemotherapy for lung cancer. Int J Radiat Oncol Biol Phys 39:91–98CrossRefPubMedGoogle Scholar
  134. Seppenwoolde Y, Engelsman M, De Jaeger K, Muller SH, Baas P, McShan DL, Fraass BA, Kessler ML, Belderbos JS, Boersma LJ, Lebesque JV (2002) Optimizing radiation treatment plans for lung cancer using lung perfusion information. Radiother Oncol 63(2):165–77CrossRefPubMedGoogle Scholar
  135. Seppenwoolde Y, Muller SH, Theuws J, et al (2000) Radiation dose-effect relations and local recovery in perfusion for patients with non-small cell lung cancer. Int J Radiat Oncol Biol Phys 47:681–691PubMedGoogle Scholar
  136. Seppenwoolde Y, Muller SH, Theuws J, et al (2000) Radiation dose-effect relations and local recovery in perfusion for patients with non-small cell lung cancer. Int J Radiat Oncol Biol Phys 47:681–691PubMedGoogle Scholar
  137. Shapiro SJ, Shapiro SD, Mill WB, Campbell EJ (1990) Prospective studyoflong-term pulmonary manifestations of mantle irradiation. Int J Radiat Oncol Biol Phys 19:707–714PubMedGoogle Scholar
  138. Simpson JR, Francis ME, Perez-Tamayo R, Marks RD, Rao DV (1985) Palliative radiotherapy for inoperable carcinoma of the lung: final report of a RTOG multi-institutional trial. Int J Radiat Oncol Biol Phys 11:751–758PubMedGoogle Scholar
  139. Strender LE, Lindahl J, Larsson LE (1986) Incidence of heart disease and functional significance of changes in the electrocardiogram 10 years after radiotherapy for breast cancer. Cancer 57:929–34PubMedGoogle Scholar
  140. Sunyach M, Falchero L, Pommier P, et al (2000) Prospective evaluation of early lung toxicity following three-dimensional conformal radiation therapy in non-small cell lung cancer: preliminary results. Int J Radiat Oncol Biol Phys 48:459–463CrossRefPubMedGoogle Scholar
  141. Sunyach M, Falchero L, Pommier P, Perol M, Appin D, Vincent M, et al (2000) Prospective evaluation of early lung toxicity following three-dimensional conformal radiation therapy in non-small cell lung cancer: preliminary results. Int J Radiat Oncol Biol PhGoogle Scholar
  142. Theuws JCM, Kwa SLS, Wagenaar AC, et al (1999) Prediction of overall pulmonary function loss in relation to the 3-D dose distribution, for patients with breast cancer and malignant lymphoma. Radiother Oncol 49:233–243CrossRefGoogle Scholar
  143. Travis EL, Harley RA, Fenn JO, Klobukowski CJ, Hargrove HB (1977) Pathologic changes in the lung following single and multi-fraction irradiation. Int J Radiat Oncol Biol Phys 2(5–6): 475–490PubMedGoogle Scholar
  144. Travis EL, Liao ZX, Tucker SL (1997) Spatial heterogeneity of the volume effect for radiation pneumonitis in mouse lung. Int J Radiat Oncol Biol Phys 38:1045–54CrossRefPubMedGoogle Scholar
  145. Travis EL (1990) The sequence of histological changes in mouse lungs after single doses of x-rays. Int J Radiat Oncol Biol Phys 6(3): 345–347Google Scholar
  146. Tsujino K, Hirota S, Endo M, et al (2003) Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 55:110–115CrossRefPubMedGoogle Scholar
  147. Tucker SL, Liao ZX, Travis EL (1997) Estimation of the spatial distribution of target cells for radiation pneumonitis in mouse lung. Int J Radiat Oncol Biol Phys 38:1055–66CrossRefPubMedGoogle Scholar
  148. Van den Brande P, De Ruysscher D, Vansteenkiste J, Spaas Ph, Specenier P, Demedts M (1998) Sequential treatment with vindesine-ifosfamide-platinum (VIP) chemotherapy followed by platinum sensitized radiotherapy in stage IIIB non-small cell lung cancer: A pGoogle Scholar
  149. van Rijswijk RE, Verbeek J, Haanen C, et al (1987) Major complications and causes of death in patients treated for Hodgkin's disease. J Clin Oncol 5:1624–33PubMedGoogle Scholar
  150. Vogt HG, Kolotas C, Martin T, et al (1996) Simultaneous radiochemotherapy with paclitaxel in non-small cell lung cancer: a clinical phase I study. Semin Oncol 23:26–30Google Scholar
  151. Wasserman T (1999) Radioprotective effects of a mifostine. Semin Oncol 26:89–94Google Scholar
  152. Watchie J, Coleman CN, Raffin TA, et al (1995) Minimal long-term cardiopulmonary dysfunction following treatment for Hodgkin's disease. Int J Radiat Oncol Biol Phys 13:517–24Google Scholar
  153. Werner-Wasik M, Scott C, Movsas B, et al (2003) Amifostine as mucosal protectant in patients with locally advanced non-small cell lung cancer (NSCLC) receiving intensive chemotherapy and thoracic radiotherapy (RT): results of the Radiation Therapy OncologyGoogle Scholar
  154. Whelan TJ, Julian J, Wright J, et al (2000) Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 18:1220–9PubMedGoogle Scholar
  155. Willner J, Jost A, Baier K, Flentje M (2003) A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy. Strahlenther OnkolGoogle Scholar
  156. Woel RT, Munley MT, Hollis D, et al (2002) The time course of radiation therapy-induced reductions in regional perfusion: a prospective study with > 5 years of follow-up. Int J Radiat Oncol Biol Phys 52:58–67CrossRefPubMedGoogle Scholar
  157. Yamada M, Kudoh S, Hirata K, Nakajima T, Yoshikawa J (1998) Risk factors of pneumonitis following chemoradiotherapy for lung cancer. Europ J Cancer 34:71–75CrossRefGoogle Scholar
  158. Yorke ED, Jackson A, Rosenzweig KE, et al (2002) Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small cell lung cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 54:3CrossRefGoogle Scholar
  159. Yorke ED, Wang L, Rosenzweig KE, Mah D, Paoli JB, Chui CS (2002) Evaluation of deep inspiration breath-hold lung treatment plans with Monte Carlo dose calculation. Int J Radiat Oncol Biol Phys 15; 53(4):1058–70.CrossRefGoogle Scholar
  160. Yu X, Prosnitz RR, Zhou S, et al (2003) Symptomatic cardiac events following radiation therapy for left-sided breast cancer: possible association with radiation therapy-induced changes in regional perfusion. Clin Breast Cancer 4:193–7PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Timothy D. Shafman
    • 1
  • Xiaoli Yu
    • 1
  • Zjelko Vujaskovic
    • 1
  • Mitchell Anscher
    • 1
  • Keith Miller
    • 1
  • Robert Prosnitz
    • 1
  • Lawrence Marks
    • 1
  1. 1.Department of Radiation OncologyDuke University Medical CenterDurhamUSA

Personalised recommendations